agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
0.572
-0.093 (-13.92%)
Mar 6, 2026, 3:27 PM EST - Market open
agilon health Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for agilon health stock have an average target of 2.66, with a low estimate of 0.50 and a high estimate of 7.50. The average target predicts an increase of 365.03% from the current stock price of 0.57.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock from 14 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 15 | 15 | 13 | 13 | 10 | 10 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 18 | 18 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $0.85 → $0.75 | Hold | Maintains | $0.85 → $0.75 | +31.12% | Mar 3, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $1 → $1.5 | Buy | Maintains | $1 → $1.5 | +162.24% | Feb 27, 2026 |
| Barclays | Barclays | Sell Maintains $1 → $0.5 | Sell | Maintains | $1 → $0.5 | -12.59% | Feb 27, 2026 |
| BTIG | BTIG | Hold Suspends n/a | Hold | Suspends | n/a | n/a | Dec 12, 2025 |
| Barclays | Barclays | Sell Maintains $1.5 → $1 | Sell | Maintains | $1.5 → $1 | +74.83% | Nov 6, 2025 |
Financial Forecast
Revenue This Year
5.73B
from 5.93B
Decreased by -3.36%
Revenue Next Year
6.14B
from 5.73B
Increased by 7.17%
EPS This Year
-0.35
from -0.95
EPS Next Year
-0.22
from -0.35
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.5B | 7.4B | |||
| Avg | 5.7B | 6.1B | |||
| Low | 5.3B | 5.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.1% | 29.3% | |||
| Avg | -3.4% | 7.2% | |||
| Low | -10.6% | -8.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.19 | -0.05 | |
| Avg | -0.35 | -0.22 | |
| Low | -0.51 | -0.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.